Akribion Therapeutics develops RNA-guided, nuclease-based technology for programmable cell depletion to treat diseases like cancer and autoimmune disorders.

Akribion Therapeutics is a biotech company developing RNA-guided, nuclease-based technology for programmable cell depletion to treat HPV-induced Oropharyngeal Head & Neck Cancer and other diseases.

Alesta Therapeutics is a biotechnology company developing oral small molecule therapies for rare diseases.

Arda Therapeutics develops targeted cell depletion therapies for chronic diseases.